Invention Grant
- Patent Title: Compositions and methods for treating CNS disorders
-
Application No.: US17695033Application Date: 2022-03-15
-
Publication No.: US11542297B2Publication Date: 2023-01-03
- Inventor: Gabriel Martinez Botella , Francesco G. Salituro , Albert Jean Robichaud , Boyd L. Harrison
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- Main IPC: C07J43/00
- IPC: C07J43/00 ; A61K9/20 ; A61K31/4164 ; A61K31/58 ; A61P25/14 ; A61P25/24 ; A61K45/06 ; C07J9/00 ; A61K31/575 ; C07J1/00 ; C07J3/00 ; C07J5/00 ; C07J7/00 ; C07J11/00 ; C07J13/00 ; C07J21/00 ; C07J31/00 ; C07J41/00 ; C07J51/00 ; C07J71/00

Abstract:
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof, wherein , A, R1, R2, R3a, R4a, R4b, R5, R7a, and R7b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
Public/Granted literature
- US20220220150A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS Public/Granted day:2022-07-14
Information query